Genmab | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Almirall EUR 35.8M 37.9M 2025-03
Amarin USD -13630000 197K 2025-03
Amgen USD 1.57B 405M 2025-06
argenx SE USD 286.9M 84.54M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Bayer EUR -426000000 2.26B 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Demant DKK 967M 76M 2024-12
Exelixis USD 230.42M 24.72M 2025-06
Fresenius Medical Care EUR 350.55M 99.9M 2025-06
Galapagos EUR -156367000 175.4M 2025-03
Genmab DKK 423M 179M 2025-06
GlaxoSmithKline GBP 1.89B 221M 2025-06
GN Store Nord DKK 114M 93M 2025-03
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 144M 144M 2024-06
Insmed USD -320443000 64.77M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 829M 127M 2025-06
Novartis USD 4.53B 124M 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
UCB EUR 1.22B 781M 2024-12


Genmab L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.